These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 17597265

  • 1. Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.
    Bienek DR, Chang CK, Cohen ME.
    Vaccine; 2007 Aug 10; 25(32):5978-84. PubMed ID: 17597265
    [Abstract] [Full Text] [Related]

  • 2. The impact of incomplete vaccination schedules on the magnitude and duration of protective antigen-specific IgG responses in recipients of the US licensed anthrax vaccine.
    Lininger LA, Cullum ME, Lyles MB, Bienek DR.
    Vaccine; 2007 Feb 19; 25(9):1619-25. PubMed ID: 17150286
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R, Porsch-Ozcürümez M, Splettstoesser W, Buckendahl A, Hahn U, Beyer W, Böhm R, Huber M, vd Esche U, Bessler W, Frangoulidis D, Finke EJ.
    Vaccine; 2007 May 04; 25(18):3679-83. PubMed ID: 17287051
    [Abstract] [Full Text] [Related]

  • 4. Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.
    Semenova VA, Schmidt DS, Taylor TH, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP.
    Vaccine; 2007 Feb 26; 25(10):1780-8. PubMed ID: 17229495
    [Abstract] [Full Text] [Related]

  • 5. Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG.
    Semenova VA, Schiffer J, Steward-Clark E, Soroka S, Schmidt DS, Brawner MM, Lyde F, Thompson R, Brown N, Foster L, Fox S, Patel N, Freeman AE, Quinn CP.
    J Immunol Methods; 2012 Feb 28; 376(1-2):97-107. PubMed ID: 22197974
    [Abstract] [Full Text] [Related]

  • 6. Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.
    Gubbins MJ, Schmidt L, Tsang RS, Berry JD, Kabani A, Stewart DI.
    J Immunoassay Immunochem; 2007 Feb 28; 28(3):213-25. PubMed ID: 17613668
    [Abstract] [Full Text] [Related]

  • 7. Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
    Rynkiewicz D, Rathkopf M, Sim I, Waytes AT, Hopkins RJ, Giri L, DeMuria D, Ransom J, Quinn J, Nabors GS, Nielsen CJ.
    Vaccine; 2011 Aug 26; 29(37):6313-20. PubMed ID: 21624418
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparability of ELISA and toxin neutralization to measure immunogenicity of Protective Antigen in mice, as part of a potency test for anthrax vaccines.
    Parreiras PM, Sirota LA, Wagner LD, Menzies SL, Arciniega JL.
    Vaccine; 2009 Jul 16; 27(33):4537-42. PubMed ID: 19501205
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.
    Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ.
    Vaccine; 2008 Aug 05; 26(33):4262-6. PubMed ID: 18586363
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109.
    Gu M, Hine PM, James Jackson W, Giri L, Nabors GS.
    Vaccine; 2007 Jan 05; 25(3):526-34. PubMed ID: 16973247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.